USANA HEALTH SCIENCES, INC. (USNA) Overview
- 5 Apr 2026: Period ending 4 Jul 2026; Estimate (m); Actual -1.16; Beat / miss (m).
- 4 Jan 2026: Period ending 4 Apr 2026; Estimate (m); Actual 0.41; Beat / miss (m).
- 29 Jun 2025: Period ending 27 Sept 2025; Estimate (m); Actual -0.36; Beat / miss (m).
- 30 Mar 2025: Period ending 28 Jun 2025; Estimate (m); Actual 0.52; Beat / miss (m).
Stock Price Chart
View more →Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
- Last close
- $13.63
- Previous close
- $14.70
- Change
- -$1.07
- Change (%)
- -7.31%
- Close date
- 2026-11-06
- Previous close date
- 2026-09-29
- Open
- (m)
- Day high
- (m)
- Day low
- (m)
- Last session volume
- (m)
- Last session value
- (m)
- Currency
- USD
- Price basis
- split-adjusted
- Volume basis
- (m)
Performance
View more →Cumulative total returns · 2026-09-29
YTD
- USNA
- -25.11%
- S&P 500
- (m)
1 year
- USNA
- -46.85%
- S&P 500
- (m)
3 years
- USNA
- -74.92%
- S&P 500
- (m)
5 years
- USNA
- -83.97%
- S&P 500
- (m)
Earnings trends
View more →Earnings per share
USD / share · As filed
4 Jul 2026 ○ Estimate (m) ● Actual -1.16
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 5 Apr 2026 | 4 Jul 2026 | (m) | -1.16 | (m) | (m) |
| 4 Jan 2026 | 4 Apr 2026 | (m) | 0.41 | (m) | (m) |
| 29 Jun 2025 | 27 Sept 2025 | (m) | -0.36 | (m) | (m) |
| 30 Mar 2025 | 28 Jun 2025 | (m) | 0.52 | (m) | (m) |
| 29 Dec 2024 | 29 Mar 2025 | (m) | 0.49 | (m) | (m) |
3 Jan 2026 ○ Estimate (m) ● Actual 0.58
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 29 Dec 2024 | 3 Jan 2026 | (m) | 0.58 | (m) | (m) |
| 31 Dec 2023 | 28 Dec 2024 | (m) | 2.19 | (m) | (m) |
| 1 Jan 2023 | 30 Dec 2023 | (m) | 3.30 | (m) | (m) |
| 2 Jan 2022 | 31 Dec 2022 | (m) | 3.59 | (m) | (m) |
| 3 Jan 2021 | 1 Jan 2022 | (m) | 5.73 | (m) | (m) |
(m)
Revenue vs. Earnings
USD
4 Jul 2026 ■ Revenue 223.27M ■ Earnings -21.38M — Profit margin -9.58%
3 Jan 2026 ■ Revenue 925.26M ■ Earnings 10.76M — Profit margin 1.16%
Analyst insights
View more →| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $13.63 | (m) | (m) | (m) | (m) |
Recent news
View more →(m)
YouTube videos mentioning USNA
View more →(m)
Statistics
View more →Retained observations as of 2026-11-11; financial period ending 4 Jul 2026.
- Forward P/E
- (m)
- PEG ratio · 5-year expected
- (m)
- Shares held by insiders
- (m)
- Insider transactions · change (%)
- (m)
- Shares held by institutions
- (m)
- Institutional transactions · change (%)
- (m)
- Diluted EPS · 12 month
- (m)
- EPS estimate · next quarter
- (m)
- EPS estimate · next year
- (m)
- EPS growth · current annual estimate
- (m)
- EPS growth · next annual estimate
- (m)
- EPS growth · next 5 years expected
- (m)
- EPS growth · past 3 years annualized
- (m)
- EPS growth · past 5 years annualized
- (m)
- EPS change · 12 months vs prior year
- (m)
- EPS change · latest quarter vs previous quarter
- (m)
- Latest earnings report date
- (m)
- EPS surprise · latest reported quarter
- (m)
- Net income · 12 month
- $-22.16M
- Gross margin · 12 months
- 77.45%
- Profit margin
- -2.43%
- Return on assets · 12 month
- -3.08%
- Named executive and board stock awards · latest fiscal year
- (m)
- Index membership
- (m)
- Employees
- 1.57K
- IPO date
- (m)
- Options available
- (m)
- Shortable
- (m)
- Analyst recommendation
- (m)
- Analyst target price
- (m)
- Price volatility · week
- (m)
- Price volatility · month
- (m)
- Average true range · 14 sessions
- (m)
- Relative strength index · 14 sessions
- (m)
- Relative volume
- (m)
- Average daily volume
- 202.49K
- Latest session volume
- (m)
- Last session value
- (m)
- 30 days ago session value
- (m)
- 1 year ago session value
- (m)
- Number of trades
- (m)
- Total return · week
- -0.54%*
- Total return · month
- 4.70%*
- Total return · quarter
- -30.03%*
- Total return · half year
- -13.12%*
- Total return · year to date
- -25.11%*
- Total return · 1 year
- -46.85%*
- Total return · 3 years
- -74.92%*
- Total return · 5 years
- -83.97%*
- Market cap
- (m)
- Book value per share · latest quarter
- (m)
- Price / cash · latest quarter
- (m)
- Enterprise value
- (m)
- Enterprise value / revenue
- (m)
- Enterprise value / EBITDA
- (m)
- Dividend · 12 months per share
- (m)
- Dividend ex-date
- (m)
- Next dividend ex-date
- (m)
- Next dividend amount per share
- (m)
- Dividend growth · 3 years annualized
- (m)
- Dividend growth · 5 years annualized
- (m)
- Revenue · 12 month
- $913.36M
- Revenue growth · past 3 years annualized
- (m)
- Revenue growth · past 5 years annualized
- (m)
- Revenue change · 12 months vs prior year
- (m)
- Revenue change · latest quarter vs previous quarter
- (m)
- Revenue surprise · latest reported quarter
- (m)
- Levered free cash flow · 12 month
- (m)
- Debt / equity · latest quarter
- (m)
- Long-term debt / equity · latest quarter
- (m)
- Return on equity · 12 month
- (m)
- Return on invested capital · 12 months
- (m)
- Previous close
- (m)
- Latest closing price
- (m)
- Latest session change (%)
- (m)
- 52-week high
- (m)
- 52-week low
- (m)
- Price vs 20-session moving average
- (m)
- Price vs 50-session moving average
- (m)
- Price vs 200-session moving average
- (m)
- Float shares
- (m)
- Short float (%)
- (m)
- Short ratio (days to cover)
- (m)
- Short interest (shares)
- (m)
Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.
Holders breakdown
View more →| Breakdown | Ownership |
|---|---|
| (m) | Shares held by all insiders |
| (m) | Shares held by institutions |
| (m) | Float held by institutions |
| (m) | Institutions holding shares |
Other holders
(m)
Insider holders
(m)
Top institutional holders
(m)
Top mutual fund holders
(m)
USANA HEALTH SCIENCES, INC. Overview
View more →(m)
(m)
- SEC CIK
- 896264
- Industry (SIC)
- 2833 Medicinal Chemicals & Botanical Products
- Country of operation
- United States
- Business address
- 3838 WEST PARKWAY BLVD., SALT LAKE CITY, Utah, 84120-6336, United States
- Fiscal year end
- 0103
- Phone
- 8019547100
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |